Inventory Turnover (Annual)

Inventory Turnover: A ratio showing how many times a company's inventory is sold and replaced over a period. Calculated as: Cost of Goods Sold / Total Inventory

Ocular Therapeutix, Inc. (OCUL) had Inventory Turnover of 1.84 for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$51.95M
Net Income	$-265.94M
Cost of Goods Sold	$6.57M
Gross Profit	$45.38M
Operating Expenses	$321.97M
Operating Income	$-270.02M
Non-Operating Income/Expense	$4.08M
Pre-Tax Income	$-265.94M
Normalized Pre-Tax Income	$-265.94M
Income after Taxes	$-265.94M
Income from Continuous Operations	$-265.94M
Consolidated Net Income/Loss	$-265.94M
Normalized Income after Taxes	$-265.94M
EBIT	$-270.02M
EBITDA	$-265.69M
Weighted-Average Shares Outstanding (Basic)	187.24M
Weighted-Average Shares Outstanding (Diluted)	187.24M
Earnings per Share (EPS) (Basic)	$-1.42
Earnings per Share (EPS) (Diluted)	$-1.42
Balance Sheet Financials
Current Assets	$782.13M
Property, Plant, and Equipment	$19.68M
Long-Term Assets	$25.93M
Total Assets	$808.06M
Current Liabilities	$50.81M
Long-Term Debt	$71.34M
Long-Term Liabilities	$102.94M
Total Liabilities	$153.75M
Common Equity	$654.31M
Tangible Shareholders Equity	$654.31M
Shareholders Equity	$654.31M
Common Shares Outstanding	215.93M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-204.88M
Cash Flow from Investing Activities	$-11.88M
Cash Flow from Financial Activities	$561.72M
Beginning Cash	$393.72M
End Cash	$738.67M
Increase/Decrease in Cash	$344.96M
Stock-Based Compensation	$43.18M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	15.39
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.10
Debt to Equity Ratio	0.11
Gross Margin	87.35%
Operating Margin	-519.75%
EBIT Margin	-519.75%
EBITDA Margin	-511.43%
Pre-Tax Profit Margin	-511.90%
Profit Margin	-511.90%
Free Cash Flow	$-216.76M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	1.84
Receiveable Turnover	1.70
Days Sales in Receivables	215.34
Return on Equity	-40.64%
Return on Tangible Equity	-40.64%
Return on Assets	-32.91%
Return on Investments	-36.65%
Book Value Per Share	$3.03
Free Cash Flow per Share	$-1.16
Operating Cash Flow per Share	$-1.09

Data from Zacks Investment Research, Inc.